title: Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis.
authors.affiliation: John Hunter Hospital, Newcastle, NSW, Australia.
authors.forename: Catherine E
authors.initials: CE
authors.lastname: Berry
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Tsai
authors.forename: Alexander
authors.initials: A
authors.lastname: Tierney
authors.forename: Robert
authors.initials: R
authors.lastname: Pickles
mesh_terms: D000068879:Adalimumab; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab